Correlation Between ContraFect and ESSA Pharma
Can any of the company-specific risk be diversified away by investing in both ContraFect and ESSA Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ContraFect and ESSA Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ContraFect and ESSA Pharma, you can compare the effects of market volatilities on ContraFect and ESSA Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ContraFect with a short position of ESSA Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ContraFect and ESSA Pharma.
Diversification Opportunities for ContraFect and ESSA Pharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between ContraFect and ESSA is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ContraFect and ESSA Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ESSA Pharma and ContraFect is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ContraFect are associated (or correlated) with ESSA Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ESSA Pharma has no effect on the direction of ContraFect i.e., ContraFect and ESSA Pharma go up and down completely randomly.
Pair Corralation between ContraFect and ESSA Pharma
If you would invest 177.00 in ESSA Pharma on April 25, 2025 and sell it today you would earn a total of 10.00 from holding ESSA Pharma or generate 5.65% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
ContraFect vs. ESSA Pharma
Performance |
Timeline |
ContraFect |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
ESSA Pharma |
ContraFect and ESSA Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ContraFect and ESSA Pharma
The main advantage of trading using opposite ContraFect and ESSA Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ContraFect position performs unexpectedly, ESSA Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ESSA Pharma will offset losses from the drop in ESSA Pharma's long position.ContraFect vs. Romana Food Brands | ContraFect vs. Aurinia Pharmaceuticals | ContraFect vs. Ingredion Incorporated | ContraFect vs. Kuke Music Holding |
ESSA Pharma vs. Summit Therapeutics PLC | ESSA Pharma vs. Spero Therapeutics | ESSA Pharma vs. Spyre Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |